High-intensity Interval Exercise in Rheumatoid Arthritis
RA-HIIT
Expected Health Benefits on Cardiovascular Function, Inflammation and Quality of Life With High-intensity Interval Exercise for Patients With Rheumatoid Arthritis
1 other identifier
interventional
87
1 country
2
Brief Summary
Cardiovascular performance and overall fitness can be improved by high-intensity aerobic activity, and these benefits may be achievable by persons with rheumatic diseases. The investigators hypothesize that a 12-week high-intensity interval exercise program will provide substantial improvements in cardiovascular function, inflammation and symptoms affecting quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable rheumatoid-arthritis
Started Aug 2021
Longer than P75 for not_applicable rheumatoid-arthritis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 16, 2021
CompletedFirst Submitted
Initial submission to the registry
September 6, 2021
CompletedFirst Posted
Study publicly available on registry
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
ExpectedDecember 22, 2025
December 1, 2025
1.9 years
September 6, 2021
December 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiopulmonary function
Maximum oxygen uptake (VO2ml/min/kg) (Higher value indicate better cardiorespiratory capacity)
0 -12 weeks
Secondary Outcomes (42)
Vascular function
0-12 weeks
Level of disease activity
0-12 weeks
Level of disease activity
0-6 months
Level of disease activity
0-12 months
Homeostatic model assessment of insulin resistance (HOMA IR)
0-12 weeks
- +37 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALCardiorespiratory and strength exercise training 2-3 sessions per week
Care as usual
NO INTERVENTIONCare as usual and information of health enhancing physical activity according to general recommendations
Interventions
Twelve weeks of supervised high intensity aerobic and resistance exercise including two sessions/week, one additional session of the patient´s own choice, non-supervised. The target of the high intensity intervals (HIIT) is 90%-95% of maximum heart rate alternated with recovery phases at 70% of maximal heart rate. The resistance exercise session of large muscle groups: 8-10 repetitions, 2-3 sets. Exercise guidance follows principles of self-efficacy and person-centeredness.
Eligibility Criteria
You may qualify if:
- Rheumatoid arthritis disease according to the American College of Rheumatology (ACR)/ The European Alliance of Associations for Rheumatology (EULAR) 1987/2010 criteria
- Disease duration \>1 year
- Age (range 20-60 years)
- Stable medication on anti- rheumatic drugs for \>3 months
- Low-to-moderate disease activity (\<5.1) according to the Disease activity score 28 (DAS28)
You may not qualify if:
- Cerebrovascular diseases
- Diabetes
- Severe hypertension
- Chronic obstructive pulmonary disease or other severe pulmonary diseases
- Other severe diseases that may be associated with adverse events or restrict participation in high-intensity exercise
- Arthroplasty of large joints
- Inability to manage Cardiopulmonary Exercise Testing (CPET)
- Pregnancy
- Already participating in regular aerobic or strength exercise at a high intensity level (\>1 hours/ week) during the last 6 months
- Inability to speak or read Swedish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vastra Gotaland Regionlead
- Göteborg Universitycollaborator
Study Sites (2)
Sahlgrenska university hospital
Gothenburg, 413 45, Sweden
Uddevalla Hospital
Uddevalla, Sweden
Related Publications (2)
Bilberg A, Bjersing J, Borjesson M, Sivertsson J, Mannerkorpi K. High-intensity exercise improves multidimensional fatigue and health-related quality of life in rheumatoid arthritis: a randomized controlled study. Arthritis Res Ther. 2025 Sep 18;27(1):176. doi: 10.1186/s13075-025-03643-3.
PMID: 40968365DERIVEDBilberg A, Mannerkorpi K, Borjesson M, Svedlund S, Sivertsson J, Klingberg E, Bjersing J. High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial. Br J Sports Med. 2024 Dec 2;58(23):1409-1418. doi: 10.1136/bjsports-2024-108369.
PMID: 39179363DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Annelie Bilberg, PhD
Vastra Gotaland Region
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Single blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2021
First Posted
March 14, 2023
Study Start
August 16, 2021
Primary Completion
June 30, 2023
Study Completion (Estimated)
December 30, 2026
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- The data will become available as following, starting 6 months after publication and end 5 years after publication.
- Access Criteria
- The requests will be reviewed by the P.I. and the steering committee. Study plans on meta-analyses generating new knowledge on exercise in persons with rheumatic diseases will be approved.
Individual participant data (IPD) that underlie results in a publication are available from the principal investigator (P.I.) on reasonable request. Access will be determined based on reasonable request and in accordance with the ethical approval